ATRA ATARA BIOTHERAPEUTICS INC Management Changes 8-K Filing 2023 - Resignation of EVP Atara Biotherapeutics announced the resignation of Jakob Dupont, EVP of R&D, who will continue to provide consulting services to the company until December 31, 2023.Get access to all SEC 8-K filings of the ATARA BIOTHERAPEUTICS INC